Non-obstructive coronary artery disease
Clinical trials for Non-obstructive coronary artery disease explained in plain language.
Never miss a new study
Get alerted when new Non-obstructive coronary artery disease trials appear
Sign up with your email to follow new studies for Non-obstructive coronary artery disease, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a Twice-Yearly shot stop artery plaque from growing?
Disease control OngoingThis study tests whether inclisiran, a drug given as a shot every 6 months, can reduce plaque buildup in the heart's arteries when added to standard statin therapy. About 608 adults with mild artery blockages (less than 50%) and no prior heart events will be randomly assigned to …
Matched conditions: NON-OBSTRUCTIVE CORONARY ARTERY DISEASE
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Can a Triple-Drug combo save Women's hearts when arteries look clear?
Disease control OngoingThis study tests whether a combination of high-dose statins, blood pressure medications (ACE inhibitors or ARBs), and low-dose aspirin can reduce the risk of death, heart attack, stroke, or hospitalization in women who have chest pain or shortness of breath but no major blockages…
Matched conditions: NON-OBSTRUCTIVE CORONARY ARTERY DISEASE
Phase 4 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC